BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33784253)

  • 1. Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses.
    Strowitzki MJ; Kimmer G; Wehrmann J; Ritter AS; Radhakrishnan P; Opitz VM; Tuffs C; Biller M; Kugler J; Keppler U; Harnoss JM; Klose J; Schmidt T; Blanco A; Taylor CT; Schneider M
    JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33784253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
    Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
    Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.
    Appelhoff RJ; Tian YM; Raval RR; Turley H; Harris AL; Pugh CW; Ratcliffe PJ; Gleadle JM
    J Biol Chem; 2004 Sep; 279(37):38458-65. PubMed ID: 15247232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.
    Chu HX; Jones NM
    Neurochem Res; 2016 Mar; 41(3):515-22. PubMed ID: 26108712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
    Willam C; Maxwell PH; Nichols L; Lygate C; Tian YM; Bernhardt W; Wiesener M; Ratcliffe PJ; Eckardt KU; Pugh CW
    J Mol Cell Cardiol; 2006 Jul; 41(1):68-77. PubMed ID: 16765982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
    Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
    J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.
    Takeda K; Ichiki T; Narabayashi E; Inanaga K; Miyazaki R; Hashimoto T; Matsuura H; Ikeda J; Miyata T; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2132-7. PubMed ID: 19762779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
    Strowitzki MJ; Ritter AS; Kimmer G; Schneider M
    Pharmacol Res; 2019 Sep; 147():104364. PubMed ID: 31376431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
    Kennel KB; Burmeister J; Radhakrishnan P; Giese NA; Giese T; Salfenmoser M; Gebhardt JM; Strowitzki MJ; Taylor CT; Wielockx B; Schneider M; Harnoss JM
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.
    Schindler K; Bondeva T; Schindler C; Claus RA; Franke S; Wolf G
    Nephrol Dial Transplant; 2016 Jul; 31(7):1100-13. PubMed ID: 26908768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
    Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
    J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis.
    Kiss J; Mollenhauer M; Walmsley SR; Kirchberg J; Radhakrishnan P; Niemietz T; Dudda J; Steinert G; Whyte MK; Carmeliet P; Mazzone M; Weitz J; Schneider M
    J Immunol; 2012 Aug; 189(4):1955-65. PubMed ID: 22786772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMOG ameliorates IFN-γ-induced intestinal barrier dysfunction by suppressing PHD2-dependent HIF-1α degradation.
    Wang WS; Liang HY; Cai YJ; Yang H
    J Interferon Cytokine Res; 2014 Jan; 34(1):60-9. PubMed ID: 24010824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.
    Li L; Saliba P; Reischl S; Marti HH; Kunze R
    Neurobiol Dis; 2016 Jul; 91():221-35. PubMed ID: 27001147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
    Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
    Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.
    Kobayashi H; Liu Q; Binns TC; Urrutia AA; Davidoff O; Kapitsinou PP; Pfaff AS; Olauson H; Wernerson A; Fogo AB; Fong GH; Gross KW; Haase VH
    J Clin Invest; 2016 May; 126(5):1926-38. PubMed ID: 27088801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trial.
    Höcker A; Rabeling M; Bick A; Cox L; Kreuzer M; Engler A; Walstein K; Bachmann HS; Jöckel KH; Eisele L; Adamzik M; Peters J; Schäfer ST
    BMC Anesthesiol; 2016 Aug; 16(1):61. PubMed ID: 27515179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.